The Valley Desk

Clinical trial reportArthritis & rheumatology (Hoboken, N.J.)Published

Pharmacodynamic Effects of Litifilimab in Lupus in a Randomized, Placebo-Controlled Phase 2 Study: Rapid and Sustained Reductions in Type I Interferon-Associated Gene Expression and Cytokines

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Philadelphia VA Medical Center, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Arthritis & rheumatology (Hoboken, N.J.)
Published
Subject terms
Humans; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Interferon Type I; Interferon-alpha; Cytokines; Treatment Outcome; Double-Blind Method; Gene Expression; Dose-Response Relationship, Drug; Adult; Middle Aged
PubMed ID
40488251
PubMed Central ID
PMC12750138
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal